Skip to main content

Table 1 Classification and clinical features of fibrillary and immunotactoid glomerulopathies

From: Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy

 

Fibrillary glomerulonephritis

Immunotactoid glomerulopathy

Composition

Fibrils

Microtubules

Fibril or microtubule size

Average diameter 18–22 nm (usual range 12–30 nm)

Typically >30 nm (range 16–90 nm)

Arrangement of fibrils or microtubules

Randomly arranged fibrils

Parallel arrays of microtubules

Immunoglobulin type

Usually polyclonal (mostly IgG4 sometimes with IGg1) occasionally monoclonal (IgGκ)

Usually monoclonal IgGκ or IgGλ

Light microscopy

Mesangial proliferation, membranoproliferative GN crescentic GN, sclerosing GN diffuse proliferative GN with endocapilliary exudation

Atypical membranous GN, diffuse proliferative GN membranoproliferative GN

Association with lymphoproliferative disorder

Uncommon

Common (chronic lymphocytic leukaemia, nonHodgkin lymphoma)

Renal presentation

Sub nephrotic or nephrotic range proteinuria + haematuria hypertension, rapidly progressive glomerulonephritis

Nephrotic syndrome with microhaematuria and hypertension

Other manifestations (fibrillar deposits)

Pulmonary haemorrhage

Microtubular inclusions in leukaemic lymphocytes

Treatment

Various immunosuppressive drugs tried with variable response (see table 1)

Treatment of the associated lymphoproliferative disorder

Racial predilection

Predominantly Caucasian

Predominantly Caucasian

Peak occurrence

5th to 6th decades

Age 60 years

Prognosis

Established renal failure in half of patients within 2–4 years

Probably better renal prognosis than fibrillary GN

Frequency in renal biopsies

Approximately 1 % of renal biopsies

0.06% of renal biopsies